Mission Bio, Onconova Therapeutics Sign Cancer Therapy Research Partnership Published on Aug 12, 2019  FDA Clears Binx Health Point-of-Care Testing Platform for Chlamydia and Gonorrhea Published on Aug 12, 2019  Top Five Articles on GenomeWeb Last Week: Stanford, Guardant Health, Illumina, and More Published on Aug 12, 2019

Featured in Depth

Quidel Updates Dx and MDx Commercial Strategies, Pipelines Published on Aug 09, 2019

TGen-Led Team Prepares to Validate 'TARDIS' Blood-Based Cancer Monitoring Method Published on Aug 09, 2019

Thermal Profiling Identifies Functionally Significant Protein Modifications Published on Aug 09, 2019

Illumina Begins Upgrading NIPT Customers to New Version of Test With Genome-Wide Options Published on Aug 09, 2019

Highly Sensitive Structural Variant Detection for Medical Genetics: A Comparison to the Standard of Care  This webinar on 9/18 will outline how a team at Radboud University Medical Center is assessing ultra-long read optical mapping on the Bionano Saphyr system to replace classical cytogenetics approaches in routine testing and for the discovery of novel structural variants with potential scientific, prognostic, or therapeutic value that are missed by standard approaches. Register Here

Recommended for You

Genetic Risk of Obesity Mitigated by Different Exercise Types, Taiwanese Study Finds Published on Aug 02, 2019  Rhythm Pharmaceuticals, PreventionGenetics to Offer Genetic Testing for Obesity Disorders Published on Jul 18, 2019

Automated Library Prep for the MCI Advantage Cancer Panel This poster from Beckman Coulter describes the automation of the MCI Advantage Cancer Panel at Miami Cancer Institute, a 170 gene panel assay based upon the Illumina TruSight Tumor 170 Panel, on the Beckman Coulter Biomek i5 Span-8 NGS Workstation. Download it from GenomeWeb’s White Paper Channel.